Ad is loading...
ABOS
Price
$2.37
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
129 days until earnings call
SNDX
Price
$15.95
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
104 days until earnings call
Ad is loading...

ABOS vs SNDX

Header iconABOS vs SNDX Comparison
Open Charts ABOS vs SNDXBanner chart's image
Acumen Pharmaceuticals
Price$2.37
Change-$0.00 (-0.00%)
Volume$180.52K
CapitalizationN/A
Syndax Pharmaceuticals
Price$15.95
Change-$0.00 (-0.00%)
Volume$1.28M
CapitalizationN/A
ABOS vs SNDX Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABOS vs. SNDX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Sell and SNDX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ABOS: $2.31 vs. SNDX: $15.60)
Brand notoriety: ABOS and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 65% vs. SNDX: 314%
Market capitalization -- ABOS: $138.78M vs. SNDX: $1.36B
ABOS [@Biotechnology] is valued at $138.78M. SNDX’s [@Biotechnology] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 5 bearish.
  • SNDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABOS and SNDX are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -11.49% price change this week, while SNDX (@Biotechnology) price change was -7.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 31, 2025.

SNDX is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.36B) has a higher market cap than ABOS($139M). SNDX YTD gains are higher at: -26.192 vs. ABOS (-39.844). ABOS has higher annual earnings (EBITDA): -77.89M vs. SNDX (-296.86M). SNDX has more cash in the bank: 406M vs. ABOS (200M). SNDX has less debt than ABOS: SNDX (854K) vs ABOS (28.5M). SNDX has higher revenues than ABOS: SNDX (16M) vs ABOS (0).
ABOSSNDXABOS / SNDX
Capitalization139M1.36B10%
EBITDA-77.89M-296.86M26%
Gain YTD-39.844-26.192152%
P/E RatioN/AN/A-
Revenue016M-
Total Cash200M406M49%
Total Debt28.5M854K3,337%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
54
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSSNDX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 16 days ago
78%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGCIX13.780.01
+0.07%
Calamos Global Opportunities I
GFVCX16.84N/A
N/A
Goldman Sachs Focused Value C
WPSGX60.03-0.09
-0.15%
AB Concentrated Growth Advisor
VAFFX32.73-0.06
-0.18%
Invesco American Franchise R6
ADECX17.96-0.04
-0.22%
Columbia Large Cap Value C

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with INZY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-2.53%
INZY - ABOS
49%
Loosely correlated
-3.58%
AURA - ABOS
49%
Loosely correlated
+3.20%
BEAM - ABOS
48%
Loosely correlated
-3.72%
GBIO - ABOS
48%
Loosely correlated
-2.22%
ALEC - ABOS
48%
Loosely correlated
+3.44%
More